Zemplar

"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...

DRUG DESCRIPTION

Paricalcitol, USP, the active ingredient in Zemplar Injection (paricalcitol injection fliptop vial) , is a synthetically
manufactured analog of calcitriol, the metabolically active form of vitamin
D indicated for the prevention and treatment of secondary hyperparathyroidism
associated with chronic kidney disease(CKD) Stage 5. Zemplar is available as
a sterile, clear, colorless, aqueous solution for intravenous injection. Each
mL contains paricalcitol, 2 mcg or 5 mcg and the following inactive ingredients:
alcohol, 20% (v/v) and propylene glycol, 30% (v/v).

Paricalcitol is a white powder chemically designated as 19-nor-1α,3β,25-trihydroxy-9,10-secoergosta­5(Z),7(E),22(E)-triene
and has the following structural formula:

Molecular formula is C27H44O3.

Molecular weight is 416.64.

What are the precautions when taking paricalcitol injection fliptop vial (Zemplar Injection)?

Before using paricalcitol, tell your doctor or pharmacist if you are allergic to it; or to other vitamin D products; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.